Cabaletta Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-67.68	-52.98	-46.29	-33.34	-22.27	-12.2
Depreciation & Amortization	3.5	3.68	0.73	0.35	0.1	0
Share-Based Compensation	11.34	6.9	5.8	4.39	2.3	0.61
Other Operating Activities	-0.71	-3.99	5.64	1.83	-1.51	6.94
Operating Cash Flow	-53.55	-46.38	-34.11	-26.77	-16.05	-4.66
Capital Expenditures	-0.69	-2.45	-1.17	-0.64	-0.69	0
Change in Investments	-21.76	-24.76	7.17	-7.35	0	0
Investing Cash Flow	-22.45	-27.22	6	-7.98	-0.69	0
Share Issuance / Repurchase	187.63	32.98	48.9	-0.02	71.22	0
Debt Issued / Paid	0	0	0	0	0	12.54
Other Financing Activities	-	-	-	-	48.71	25.14
Financing Cash Flow	187.63	32.98	48.9	-0.02	119.93	37.68
Net Cash Flow	111.63	-40.62	20.79	-34.78	103.19	33.02
Free Cash Flow	-54.24	-48.83	-35.28	-27.41	-16.74	-4.66
Free Cash Flow Per Share	-1.27	-1.68	-1.25	-1.14	-0.70	-2.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).